NCT06509113 A Pilot Study of an Online HIV Stigma Training for Nursing Students in Iran
| NCT ID | NCT06509113 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Stigma, Social |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2024-09-15 |
| Primary Completion | 2025-09-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2024-09-15 with a primary completion date of 2025-09-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study, the investigators will assess the feasibility, acceptability, and preliminary efficacy of online HIV stigma training in reducing stigmatizing attitudes and behaviors of nursing students in simulated clinical visits of patients living with HIV compared to an online HIV epidemiology training with no specific content on stigma.
Eligibility Criteria
Inclusion Criteria: * Currently nursing students in their year 3 or 4 of training * Kerman Medical University (KMU) nursing schools Exclusion Criteria: * Nursing student in their year 1 and 2 * Students of other fields and other universities
Contact & Investigator
Ali Mirzazadeh, PhD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT06509113 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stigma, Social. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06509113 currently recruiting?
Yes, NCT06509113 is actively recruiting participants. Contact the research team at sharifihami@gmail.com for enrollment information.
Where is the NCT06509113 trial being conducted?
This trial is being conducted at Kerman, Iran.
Who is sponsoring the NCT06509113 clinical trial?
NCT06509113 is sponsored by University of California, San Francisco. The principal investigator is Ali Mirzazadeh, PhD at University of California, San Francisco. The trial plans to enroll 70 participants.